160 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
30 May 24
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
4:08pm
Larimar’s ability to develop and commercialize nomlabofusp (also known as CTI-1601) and other planned product candidates, Larimar’s planned research … and development efforts, including the timing of its nomlabofusp clinical trials, expectations with respect to the START program, interactions
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
20 May 24
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
4:08pm
product candidates, Larimar’s planned research and development efforts, including the timing of its nomlabofusp clinical trials, interactions
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
20 May 24
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
4:08pm
nomlabofusp (CTI-1601) and other planned product candidates, Larimar’s planned research and development efforts, including the timing of its nomlabofusp
8-K
EX-99.1
t75gn k1b
9 May 24
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
7:02am
8-K
EX-99.2
lcq a8h35
9 May 24
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
7:02am
PRE 14A
x27mrw7nfnd yao8vpco
12 Apr 24
Preliminary proxy
6:06am
8-K
EX-99.1
sob21r8 ro
14 Mar 24
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
4:06pm
8-K
EX-99.3
a0qkfre3v56 pn9a
11 Mar 24
Other Events
4:09pm
8-K
EX-99.1
y1fn50 1k7igjrp1
11 Mar 24
Other Events
4:09pm
8-K
EX-99.2
yjdt6rvyhfk1i
11 Mar 24
Other Events
4:09pm
424B5
r0rgg
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
ffcv0fjv
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.1
fbk3dfiuqbhxxx
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
gvuwnaml94ez70sfgu5
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.3
2gp5h c17ofua4b1lt
12 Feb 24
Results of Operations and Financial Condition
7:03am